The study aims to assess how hyperbaric oxygen therapy (HBOT) affects the retina and choroid in healthy eyes, measuring central macular thickness and other retinal features.
Thirty-five participants, aged 22 to 59, underwent HBOT and had their macular thickness measured before and after the first and twentieth sessions, showing a significant decrease in central macular thickness after treatment.
While HBOT resulted in significant thinning of the macula, other retinal measurements showed no notable differences, suggesting HBOT might complement existing treatments for macular edema without adversely affecting other retinal structures.